CIENCIASMEDICASNEWS: Medical News | Medical Articles: Lipsomes for Brain Drug Delivery

miércoles, 5 de febrero de 2020

Medical News | Medical Articles: Lipsomes for Brain Drug Delivery

	Alzheimer's Disease
	The latest Alzheimer's disease news from News Medical

Lipsomes for Brain Drug Delivery

Alzheimer’s disease, in spite of being the sixth main cause of death in the US, has only five drug treatments approved, due to the failure of drug development for central nervous system (CNS) diseases in clinical trials. This is caused by the selective permeability of the blood-brain-barrier (BBB).

Read Full Article Here

			New compound prevents amyloid formation to fight Alzheimer’s disease It is known that Alzheimer’s disease is caused by the formation of amyloid plaques and tau tangles in the brain. A novel compound shows promise in preventing amyloid formation, fighting Alzheimer’s disease development.

			Can Concussions Increase the Risk of Dementia? The first symptoms of a head injury such as confusion, memory loss and changes in speech and vision can resemble those seen in dementia. Depending on how severe the injury is, such symptoms may resolve quickly, last a long time or never completely go away.

	Dementia patients being admitted to hospital for emergencies up by 35 percent Dementia, a neurodegenerative and debilitating illness can take a toll on the life of older adults. In a recent report, the number of patients with dementia being rushed to emergency rooms rose by a staggering 35 percent in five years.

	Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s? A common pathological hallmark of many neurodegenerative diseases is the presence of oxidative stress caused by an accumulation of reactive oxygen species (ROS).

	Is Cocoa Good for the Brain? One of the most fascinating scientific challenges is to enhance human cognitive abilities. Research interests have been focused on preventing age-related cognitive decline and sustaining optimal cognitive performance in cognitively demanding situations.

	Regular aerobic exercise could enhance cognitive functions in adults at risk for Alzheimer’s Individuals at risk for Alzheimer's disease (AD) because of family history or genetic predisposition who engaged in six months of aerobic exercise training improved their brain glucose metabolism and higher-order thinking abilities (e.g., planning and mental flexibility) called executive function; these improvements occurred in conjunction with increased cardiorespiratory fitness.

	Potential new biomarker for vascular dementia identified Vascular dementia is caused by a defect on blood flow arrival to the brain, which consequently generates neuronal damage.